High-density lipoproteins: an emerging target in the prevention of cardiovascular disease

被引:20
|
作者
Cutri, Belinda A.
Hime, Neil J.
Nicholls, Stephen J.
机构
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[3] Heart Res Inst, Sydney, NSW 2050, Australia
关键词
high-density lipoproteins; cardiovascular disease; atherosclerotic plaque; stabilises lesions;
D O I
10.1038/sj.cr.7310097
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
High-density lipoproteins (HDLs) have been well established to protect against the development of atherosclerotic cardiovascular disease. It has become apparent that in addition to the promotion of reverse cholesterol transport, HDLs possess a number of additional functional properties that may contribute to their beneficial influence on the arterial wall. A number of exciting therapeutic strategies have been developed that target HDL and its ability to protect against the development of atherosclerotic plaque. This paper will review how the promotion of the functional properties of HDL inhibits the formation of atherosclerotic plaque and stabilises lesions in patients with established disease.
引用
收藏
页码:799 / 808
页数:10
相关论文
共 50 条
  • [31] Recombinant high-density lipoproteins and their use in cardiovascular diseases
    Cao, Yi-ni
    Xu, Lu
    Han, Ying-chun
    Wang, Yu-nan
    Liu, George
    Qi, Rong
    DRUG DISCOVERY TODAY, 2017, 22 (01) : 180 - 185
  • [32] Focus on high-density lipoproteins in reducing cardiovascular risk
    Brewer, HB
    AMERICAN HEART JOURNAL, 2004, 148 (01) : S14 - S18
  • [33] Raising high-density lipoprotein cholesterol for better prevention of cardiovascular disease
    Birjmohun, Rakesh S.
    Stroes, Erik S. G.
    Kastelein, John J. P.
    FUTURE LIPIDOLOGY, 2006, 1 (01): : 47 - 54
  • [34] HIGH-DENSITY LIPOPROTEINS
    WITZTUM, J
    SCHONFELD, G
    DIABETES, 1979, 28 (04) : 326 - 333
  • [35] Antibodies to high-density lipoproteins are associated with inflammation and cardiovascular disease in rheumatoid arthritis patients
    Rodriguez-Carrio, Javier
    Alperi-Lopez, Mercedes
    Lopez, Patricia
    Ballina-Garcia, Francisco J.
    Abal, Francisco
    Suarez, Ana
    TRANSLATIONAL RESEARCH, 2015, 166 (06) : 529 - 539
  • [36] High-density lipoprotein therapeutics and cardiovascular prevention
    Fazio, Sergio
    Linton, MacRae F.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (05) : 411 - 419
  • [37] High-density lipoproteins and cardiovascular risk: review of the evidence and doubts
    Alvarez-Sala Walther, L. A.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2010, 22 : 3 - 8
  • [38] Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk
    Zewinger, Stephen
    Drechsler, Christiane
    Kleber, Marcus E.
    Dressel, Alexander
    Riffel, Julia
    Triem, Sarah
    Lehmann, Marlene
    Kopecky, Chantal
    Saeemann, Marcus D.
    Lepper, Philipp M.
    Silbernagel, Guenther
    Scharnagl, Hubert
    Ritsch, Andreas
    Thorand, Barbara
    Gala, Tonia de las Heras
    Wagenpfeil, Stefan
    Koenig, Wolfgang
    Peters, Annette
    Laufs, Ulrich
    Wanner, Christoph
    Fliser, Danilo
    Speer, Thimoteus
    Maerz, Winfried
    EUROPEAN HEART JOURNAL, 2015, 36 (43) : 3007 - 3016
  • [39] Health benefits of high-density lipoproteins in preventing cardiovascular diseases
    Berrougui, Hicham
    Momo, Claudia N.
    Khalil, Abdelouahed
    JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (06) : 524 - 533
  • [40] HIGH-DENSITY LIPOPROTEINS AND CORONARY-ARTERY DISEASE
    不详
    CANADIAN JOURNAL OF MEDICAL TECHNOLOGY, 1979, 41 (06): : E237 - E237